...
首页> 外文期刊>Biomedical Engineering, IEEE Transactions on >Optimal Control of Inspired Perfluorocarbon Temperature for Ultrafast Hypothermia Induction by Total Liquid Ventilation in an Adult Patient Model
【24h】

Optimal Control of Inspired Perfluorocarbon Temperature for Ultrafast Hypothermia Induction by Total Liquid Ventilation in an Adult Patient Model

机译:通过全液体通气在成年患者模型中诱导超氟化物诱导全氟化碳温度的最佳控制

获取原文
获取原文并翻译 | 示例

摘要

Goal: Recent preclinical studies have shown that therapeutic hypothermia induced in less than 30 min by total liquid ventilation (TLV) strongly improves the survival rate after cardiac arrest. When the lung is ventilated with a breathable perfluorocarbon liquid, the inspired perfluorocarbon allows us to control efficiently the cooling process of the organs. While TLV can rapidly cool animals, the cooling speed in humans remains unknown. The objective is to predict the efficiency and safety of ultrafast cooling by TLV in adult humans. Methods: It is based on a previously published thermal model of ovines in TLV and the design of a direct optimal controller to compute the inspired perfluorocarbon temperature profile. The experimental results in an adult sheep are presented. The thermal model of sheep is subsequently projected to a human model to simulate the optimal hypothermia induction and its sensitivity to physiological parameter uncertainties. Results: The results in the sheep showed that the computed inspired perfluorocarbon temperature command can avoid arterial temperature undershoot. The projection to humans revealed that mild hypothermia should be ultrafast (reached in fewer than 3 min (-72 °C/h) for the brain and 20 min (-10 °C/h) for the entire body). Conclusion: The projection to human model allows concluding that therapeutic hypothermia induction by TLV can be ultrafast and safe. Significance: This study is the first to simulate ultrafast cooling by TLV in a human model and is a strong motivation to translate TLV to humans to improve the quality of life of postcardiac arrest patients.
机译:目的:最新的临床前研究表明,在不到30分钟的时间内,通过全液体通气(TLV)引起的治疗性体温过高可以大大提高心脏骤停后的生存率。当肺用可吸入的全氟化碳液体通风时,吸入的全氟化碳使我们能够有效地控制器官的冷却过程。尽管TLV可以迅速冷却动物,但人类的冷却速度仍然未知。目的是预测TLV在成人中超快冷却的效率和安全性。方法:它基于先前发布的TLV中绵羊的热模型和直接最佳控制器的设计,以计算灵感的全氟化碳温度曲线。介绍了成年绵羊的实验结果。随后将绵羊的热模型投影到人体模型,以模拟最佳的低温诱导及其对生理参数不确定性的敏感性。结果:绵羊的结果表明,计算得出的全氟化碳吸气温度指令可以避免动脉温度下冲。对人类的预测表明,亚低温应该是超快的(对大脑而言,不到3分钟(-72°C / h),对整个身体不到20分钟(-10°C / h)。结论:对人体模型的预测可以得出结论,TLV诱导治疗性体温过低是安全的。意义:该研究是第一个在人类模型中模拟TLV超快冷却的研究,并且是将TLV转化为人类以改善明信片骤停患者生活质量的强烈动机。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号